{"id":"W2165461376","doi":"10.1161/01.str.0000127084.26321.7a","title":"Health Care Resource Use After Acute Stroke in the Glycine Antagonist in Neuroprotection (GAIN) Americas Trial","year":2004,"lang":"en","type":"article","venue":"Stroke","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovative Targeting Solutions (Canada); Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"National Institute of Neurological Disorders and Stroke; GlaxoSmithKline","keywords":"Medicine; Stroke (engine); Rehabilitation; Emergency medicine; Health care; Intensive care unit; Proportional hazards model; Physical therapy; Clinical trial; Intensive care medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001178175,0.0004703787,0.001285266,0.000240826,0.0005895115,0.0009632348,0.0005057917,0.0007616411,0.001727791],"category_scores_gemma":[0.001994263,0.0001553071,0.001085076,0.0007214507,0.0005233395,0.000387383,0.0004994308,0.0007720907,0.0001207277],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002781949,"about_ca_system_score_gemma":0.006304218,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1170159,"about_ca_topic_score_gemma":0.2743827,"domain_scores_codex":[0.9992488,0.0002688778,0.00005902813,0.0001059218,0.0001416938,0.0001755417],"domain_scores_gemma":[0.9991506,0.0001568964,0.0002145049,0.00004262599,0.0001558752,0.0002794048],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6185606,0.00227103,0.2850781,0.003491201,0.01531221,0.0002677773,0.0002757472,0.00173582,0.00117889,0.0007822261,0.01376579,0.05728046],"study_design_scores_gemma":[0.2806663,0.01855085,0.6717526,0.0009483347,0.01388638,0.0004335131,0.0004678242,0.001694529,0.0005515411,0.0007444728,0.010216,0.00008773611],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854607,0.007609031,0.00006158333,0.001073728,0.00009279315,0.0003535824,0.002717083,0.00001456743,0.002616926],"genre_scores_gemma":[0.9884573,0.003710364,0.0002917949,0.0009466875,0.0001858362,0.0005295931,0.004781624,0.000005651775,0.001091166],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1170159,"threshold_uncertainty_score":0.2326697,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01667909481128362,"score_gpt":0.291200398301669,"score_spread":0.2745213034903854,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}